HK1131970A1 - Method for the synthesis of n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine<0} - Google Patents

Method for the synthesis of n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine<0}

Info

Publication number
HK1131970A1
HK1131970A1 HK09109840.4A HK09109840A HK1131970A1 HK 1131970 A1 HK1131970 A1 HK 1131970A1 HK 09109840 A HK09109840 A HK 09109840A HK 1131970 A1 HK1131970 A1 HK 1131970A1
Authority
HK
Hong Kong
Prior art keywords
benzoxathiepin
sulfanyl
methylpropyl
methoxyphenyl
dihydro
Prior art date
Application number
HK09109840.4A
Other languages
English (en)
Inventor
Bernard Vacher
Yves Brunel
Maurel J Jean-Louis
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of HK1131970A1 publication Critical patent/HK1131970A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HK09109840.4A 2006-11-08 2009-10-23 Method for the synthesis of n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine<0} HK1131970A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609815A FR2908132B1 (fr) 2006-11-08 2006-11-08 Procede de synthese du n-[3-[(2-methoxyphenyl)sulfanyl]-2- methylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine
PCT/FR2007/001831 WO2008068403A2 (fr) 2006-11-08 2007-11-06 Procede de synthese du n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine

Publications (1)

Publication Number Publication Date
HK1131970A1 true HK1131970A1 (en) 2010-02-12

Family

ID=38066470

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109840.4A HK1131970A1 (en) 2006-11-08 2009-10-23 Method for the synthesis of n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine<0}

Country Status (27)

Country Link
US (1) US7982054B2 (ko)
EP (1) EP2089374B1 (ko)
JP (1) JP5180965B2 (ko)
KR (1) KR101390486B1 (ko)
CN (1) CN101535287B (ko)
AR (1) AR063592A1 (ko)
AT (1) ATE476429T1 (ko)
AU (1) AU2007330711B2 (ko)
BR (1) BRPI0718702A2 (ko)
CA (1) CA2668951C (ko)
DE (1) DE602007008284D1 (ko)
ES (1) ES2350324T3 (ko)
FR (1) FR2908132B1 (ko)
HK (1) HK1131970A1 (ko)
IL (1) IL198528A (ko)
MA (1) MA30800B1 (ko)
MX (1) MX2009003957A (ko)
NO (1) NO20091980L (ko)
NZ (1) NZ576442A (ko)
PL (1) PL2089374T3 (ko)
PT (1) PT2089374E (ko)
RU (1) RU2414464C9 (ko)
TN (1) TN2009000176A1 (ko)
TW (1) TWI397527B (ko)
UA (1) UA94632C2 (ko)
WO (1) WO2008068403A2 (ko)
ZA (1) ZA200902732B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2979823B1 (fr) * 2011-09-13 2013-09-27 Pf Medicament Utilisation du 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methyl-propyl]amino-3,4-dihydro-2h-1,5-benzoxathiepine pour le traitement du cancer et en particulier pour la prevention et/ou le traitement des metastases cancereuses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868779B1 (fr) * 2004-04-09 2008-08-22 Pierre Fabre Medicament Sa Procede de synthese et intermediaires de benzoxathiepines

Also Published As

Publication number Publication date
CN101535287A (zh) 2009-09-16
AU2007330711B2 (en) 2011-11-03
EP2089374B1 (fr) 2010-08-04
WO2008068403A3 (fr) 2008-11-27
JP5180965B2 (ja) 2013-04-10
ES2350324T3 (es) 2011-01-21
MA30800B1 (fr) 2009-10-01
US7982054B2 (en) 2011-07-19
AU2007330711A1 (en) 2008-06-12
TW200835688A (en) 2008-09-01
WO2008068403A2 (fr) 2008-06-12
RU2009121560A (ru) 2010-12-20
FR2908132B1 (fr) 2008-12-19
NZ576442A (en) 2012-03-30
ZA200902732B (en) 2010-02-24
DE602007008284D1 (de) 2010-09-16
PT2089374E (pt) 2010-11-04
CA2668951C (fr) 2012-06-26
IL198528A (en) 2012-12-31
MX2009003957A (es) 2009-04-28
AR063592A1 (es) 2009-02-04
PL2089374T3 (pl) 2011-01-31
KR101390486B1 (ko) 2014-05-19
CN101535287B (zh) 2013-02-27
IL198528A0 (en) 2010-02-17
FR2908132A1 (fr) 2008-05-09
NO20091980L (no) 2009-06-08
RU2414464C9 (ru) 2011-11-10
RU2414464C2 (ru) 2011-03-20
UA94632C2 (en) 2011-05-25
EP2089374A2 (fr) 2009-08-19
ATE476429T1 (de) 2010-08-15
BRPI0718702A2 (pt) 2014-01-07
TWI397527B (zh) 2013-06-01
TN2009000176A1 (fr) 2010-10-18
JP2010509296A (ja) 2010-03-25
CA2668951A1 (fr) 2008-06-12
US20090318709A1 (en) 2009-12-24
KR20090082463A (ko) 2009-07-30

Similar Documents

Publication Publication Date Title
WO2006034093A3 (en) 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
EA200801560A1 (ru) Бифенилкарбоксамиды
NO20072930L (no) Tripentylcitrater og deres anvendelse
EA200602038A1 (ru) Азинилимидазоазины и азинилкарбоксамиды
EA200701822A1 (ru) Пиразолилкарбоксанилиды
SI1824479T1 (sl) Derivati fenilpiperazina s kombinacijo delnega dopamin-d2 receptorskega agonizma in inhibiranje ponovnega privzema serotonina
WO2007143113A3 (en) The use of enzymatic resolution for the preparation of intermediates of pregabalin
CY1108079T1 (el) Μeθοδος καθαρισμοy μεσοτριoνης
HK1131970A1 (en) Method for the synthesis of n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine&lt;0}
DE502008002059D1 (de) Verwendung amphoterer Ionenaustauscher
GB0512284D0 (en) Organic compounds
WO2007119004A3 (fr) Methode de diagnostic in vitro ou ex vivo de desordres psychiatriques et/ou de dysbioses intestinales
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
ATE500340T1 (de) Enzymatische reduktion zur herstellung optisch aktiver alkohole
Bakthadoss et al. Simple and new protocol for the synthesis of novel (z)-3-arylidenebenzothiazepin-4-ones using Baylis–Hillman derivatives
ATE499924T1 (de) Kosmetische zusammensetzung enthaltend einen ester eines alkoxylierten alkohols und einen kohlenwasserstoff-ester
DE60332284D1 (de) Optisches aufzeichnungsmedium; stanzer zur herstellung des optischen aufzeichnungsmediums
WO2008047129A3 (en) Latent fluorescent probes
EA200500818A1 (ru) Абсолютное количественное определение нуклеиновых кислот от-пцр
TW200634009A (en) Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
WO2005015990A8 (en) New diabetes type 2 animal model
SHEN et al. Direct asymmetric aldol reactions catalyzed by (4S)-phenoxy-(S)-proline
DE60220524D1 (de) C-2&#39;-methylierte paclitaxel-derivate zur verwendung als antitumorale mittel
FR2908413B1 (fr) Marqueur specifique d&#39;une degradation oxydative de tissus contenant du collagene de type iii,moyens et methodes,kits de diagnostic de suivi ou de pronostic des pathologies ciblees par ce marqueur.
UA3489U (uk) Спосіб культивування личинок nippostrongylus braziliensis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181103